127 related articles for article (PubMed ID: 16081032)
1. Autoimmunity, alloimmunization and immunotherapy of AIDS.
Bourinbaiar AS; Abulafia-Lapid R
Autoimmun Rev; 2005 Jul; 4(6):403-9. PubMed ID: 16081032
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with therapeutic AIDS vaccines.
Bourinbaiar AS; Abulafia-Lapid R
Expert Rev Vaccines; 2005 Jun; 4(3):289-304. PubMed ID: 16026245
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic AIDS vaccines.
Bourinbaiar AS; Root-Bernstein RS; Abulafia-Lapid R; Rytik PG; Kanev AN; Jirathitikal V; Orlovsky VG
Curr Pharm Des; 2006; 12(16):2017-30. PubMed ID: 16787245
[TBL] [Abstract][Full Text] [Related]
4. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
5. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
Leligdowicz A; Rowland-Jones S
Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
[TBL] [Abstract][Full Text] [Related]
6. Design of effective immunotherapy for human autoimmunity.
Feldmann M; Steinman L
Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
[TBL] [Abstract][Full Text] [Related]
7. [Development of an AIDS vaccine: status report].
Girard MP
Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
[TBL] [Abstract][Full Text] [Related]
8. Immune therapies of autoimmune diseases: are we approaching a real cure?
Chatenoud L
Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
[TBL] [Abstract][Full Text] [Related]
9. Approaches to AIDS therapy.
Klatzmann D; Montagnier L
Nature; 1986 Jan 2-8; 319(6048):10-11. PubMed ID: 3001533
[No Abstract] [Full Text] [Related]
10. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
Miller SD; Turley DM; Podojil JR
Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
12. Prime-boost strategies in DNA vaccines.
Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
[TBL] [Abstract][Full Text] [Related]
13. Human trials of AIDS vaccines: novel means of passive and active immunotherapy.
Dalgleish AG
AIDS; 1988; 2 Suppl 1():S129-31. PubMed ID: 3147663
[No Abstract] [Full Text] [Related]
14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
15. Is a vaccine against AIDS possible?
Langley D; Spier RE
Vaccine; 1988 Feb; 6(1):3-5. PubMed ID: 3354255
[TBL] [Abstract][Full Text] [Related]
16. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
17. [AIDS vaccines and immunotherapy of infertility].
Bourinbaiar AS; Jirathitikal V; Hoffmann GW; Lu NQ
Zhonghua Nan Ke Xue; 2005 Mar; 11(3):163-9. PubMed ID: 15804104
[TBL] [Abstract][Full Text] [Related]
18. [AIDS--an HIV-induced autoimmune disease?].
Bicker U; Wieczorek L
Fortschr Med; 1987 Sep; 105(26):497-8. PubMed ID: 2959603
[No Abstract] [Full Text] [Related]
19. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
20. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
